Today, the global healthcare system is at this breaking point, at maxQ, with an urgent need for solutions that will bring economic relief and increase patient care outcomes and capacity. Physicians need seamlessly integrated solutions that provide clinical insights and answers, empowering their decisions to recommend better treatment and, ultimately, save lives.
At MaxQ AI, our mission is to reinvent patient diagnosis through artificial intelligence (AI), improved triaging and diagnostics processes, and reduction of avoidable medical errors and costs —all leading to better patient outcomes.
MaxQ AI is at the forefront of transforming healthcare by empowering physicians to provide “smarter care” through intelligent imaging with actionable insights. We are committed to harnessing the power of artificial intelligence (AI) to raise the level of acute care in hospitals all around the world. We strive to deliver expert results to the physicians that save lives, improve care quality, and lower healthcare costs.
Our software suite is being designed to comprise several AI applications branded under the name ACCIPIO (meaning “to learn” in Latin). ACCIPIO uses artificial intelligence for the comprehensive, seamless, and secure assessment of non-contrast head CT for intracranial hemorrhage (ICH) prioritization, triage, annotation, quantification, and rule-out.
At MaxQ AI, we are revolutionizing acute care and treatment with the help of world-class clinical partners and state-of-the-art technology. Our global influence in the new era of AI-empowered care will make it possible for all physicians to access expert-level insights across the diagnosis, prognosis, and therapeutic pathways, making an important difference in the lives of patients and physicians alike.
MaxQ AI is a healthcare technology company developing innovative medical diagnostic artificial intelligence software to augment emergency room physicians in their daily practice. We prioritize absolute rigor in all certifications, systems, security, and compliance to ensure the company behind the suite leads by example.
The “maxQ condition” is the point in flight when a space vehicle reaches maximum dynamic pressure, often the point when a catastrophic failure occurs.
Today, the global healthcare system is at this breaking point, at maxQ, with an urgent need for solutions that will bring economic relief and increase patient care outcomes and capacity.
Physicians need seamlessly integrated solutions that provide clinical insights and answers, empowering their decisions to recommend better treatment and, ultimately, save lives.
Every patient deflected from stroke to wellness is a net benefit to the bottom line. On average, $150,000 per year in costs is required for stroke support/rehab of a patient*.
Payor/Providers are typically comprised of major metro centers with an academic “hub” and large, networked community facilities.
Compounded with the reality that many community facilities have only emergency department support, with no radiologist to read, or sub-specialty neuroradiologist to escalate the case for assistance – there is a large unmet need that can benefit from the “better together” result of ACCIPIO and the physician.
With many community facilities having only emergency department support, along with no radiologist to read on nights and weekends, and a lack of sub-specialty neuroradiologists to escalate cases, there is often a lack of confidence of treating locally.
In this setting, the lack of confidence in identifying ICH can lead to unwarranted institutional transfer, withholding life-saving stroke care, and delayed action. This can have significant consequences for the patient, physician, and facility.
ACCIPIO provides projected expertise allowing the local facility, which makes the majority of care decisions, to determine the next, best treatment decision on treating there and now, or escalating further to additional resources.
In larger facilities, resources and escalation are not the primary issues. Effective use of these resources and a high-volume of patients are the areas of greatest need.
Having multiple head CT cases stacked in the queue, with no timely prioritization or triage for ICH, is common.
Key resources being used for “stoke mimics”, sent from the network community hospital, divert attention away from those in the greatest need. Over-escalating cases to neuroradiologists diverts attention from the patients that need it most. Mobile Stroke Units (MSU) can transmit early imaging data that helps guide patient routing and preparation of on-arrival resources.
We will provide enhanced escalation and intervention confidence, including mobilization of neurosurgery, thrombolysis, and thrombectomy resources for the right care readied faster.
The recipient of the Mobile Stroke Unit or Life-Flight unit should provide the needed information before they arrive to determine which is the best care facility.
We will improve potential diagnostic quality, confidence, speed, prioritization, and escalation to experts, extending the reach of department specialists.
This enables the possibility of better care in all market segments by bringing rapid clinical confidence to the reader while reducing variability across a care network.
The sheer volume of case-load, image counts, and decreasing physician availability demands a real solution to the burn-out of these front-line care providers.
The applications MaxQ AI has developed will help empower physicians to provide “smarter care” with artificial intelligence-based clinical insights, resulting in potential diagnostic improvements, which may lead to better patient outcomes and lower healthcare costs. When minutes matter for patients in acute care, ACCIPIO® and the skilled care provider are better together.
In seconds, MaxQ AI applications are being designed to seamlessly prioritize, triage, rule out, annotate, quantify, and notify in the acute care setting. Seamlessly assisting the physicians in making rapid clinical diagnosis and next-step decisions for the patient, where every minute counts.